CrowdStrike Holdings, Inc. (NASDAQ:CRWD – Get Free Report)’s share price traded down 0.6% on Monday . The stock traded as low as $295.08 and last traded at $301.40. 770,961 shares traded hands during mid-day trading, a decline of 85% from the average session volume of 5,086,936 shares. The stock had previously closed at $303.13.
Wall Street Analyst Weigh In
Several analysts recently weighed in on the stock. Wells Fargo & Company reduced their price objective on shares of CrowdStrike from $435.00 to $350.00 and set an “overweight” rating on the stock in a research note on Monday, July 22nd. Oppenheimer reduced their price objective on shares of CrowdStrike from $450.00 to $365.00 and set an “outperform” rating on the stock in a research note on Thursday, August 29th. Piper Sandler reissued an “overweight” rating and issued a $290.00 price objective on shares of CrowdStrike in a research note on Thursday, September 19th. Barclays boosted their price objective on shares of CrowdStrike from $285.00 to $295.00 and gave the stock an “overweight” rating in a research note on Thursday, August 29th. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $400.00 price target on shares of CrowdStrike in a research report on Monday. One analyst has rated the stock with a sell rating, six have assigned a hold rating, thirty-one have issued a buy rating and three have assigned a strong buy rating to the company. Based on data from MarketBeat.com, CrowdStrike presently has a consensus rating of “Moderate Buy” and an average target price of $328.74.
CrowdStrike Stock Down 0.2 %
CrowdStrike (NASDAQ:CRWD – Get Free Report) last issued its quarterly earnings results on Wednesday, August 28th. The company reported $1.04 earnings per share for the quarter, topping the consensus estimate of $0.97 by $0.07. The business had revenue of $963.87 million for the quarter, compared to analysts’ expectations of $958.27 million. CrowdStrike had a net margin of 4.84% and a return on equity of 8.44%. The company’s revenue was up 31.7% compared to the same quarter last year. During the same quarter last year, the company posted $0.06 EPS. On average, equities research analysts expect that CrowdStrike Holdings, Inc. will post 0.52 EPS for the current fiscal year.
Insider Activity at CrowdStrike
In related news, Director Sameer K. Gandhi sold 6,250 shares of CrowdStrike stock in a transaction on Friday, October 11th. The shares were sold at an average price of $320.38, for a total transaction of $2,002,375.00. Following the transaction, the director now owns 821,766 shares in the company, valued at approximately $263,277,391.08. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, Director Sameer K. Gandhi sold 6,250 shares of the company’s stock in a transaction dated Friday, October 11th. The shares were sold at an average price of $320.38, for a total transaction of $2,002,375.00. Following the transaction, the director now directly owns 821,766 shares in the company, valued at approximately $263,277,391.08. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO George Kurtz sold 55,325 shares of the company’s stock in a transaction dated Monday, September 23rd. The stock was sold at an average price of $296.62, for a total transaction of $16,410,501.50. Following the completion of the transaction, the chief executive officer now owns 1,109,746 shares in the company, valued at $329,172,858.52. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 103,212 shares of company stock worth $30,529,413. 4.34% of the stock is owned by corporate insiders.
Institutional Trading of CrowdStrike
A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. increased its stake in shares of CrowdStrike by 2.0% in the first quarter. Vanguard Group Inc. now owns 16,061,400 shares of the company’s stock worth $5,149,124,000 after acquiring an additional 315,280 shares during the period. Legal & General Group Plc grew its position in CrowdStrike by 3.0% during the second quarter. Legal & General Group Plc now owns 2,049,704 shares of the company’s stock valued at $785,425,000 after buying an additional 60,607 shares during the period. Ameriprise Financial Inc. grew its position in CrowdStrike by 4.4% during the second quarter. Ameriprise Financial Inc. now owns 1,817,387 shares of the company’s stock valued at $696,471,000 after buying an additional 77,100 shares during the period. Bank of New York Mellon Corp grew its position in CrowdStrike by 47.5% during the second quarter. Bank of New York Mellon Corp now owns 1,753,252 shares of the company’s stock valued at $671,828,000 after buying an additional 564,662 shares during the period. Finally, Federated Hermes Inc. grew its position in CrowdStrike by 0.9% during the second quarter. Federated Hermes Inc. now owns 1,112,272 shares of the company’s stock valued at $426,212,000 after buying an additional 9,564 shares during the period. Institutional investors and hedge funds own 71.16% of the company’s stock.
About CrowdStrike
CrowdStrike Holdings, Inc provides cybersecurity solutions in the United States and internationally. Its unified platform offers cloud-delivered protection of endpoints, cloud workloads, identity, and data. The company offers corporate endpoint and cloud workload security, managed security, security and vulnerability management, IT operations management, identity protection, SIEM and log management, threat intelligence, data protection, security orchestration, automation and response and AI powered workflow automation, and securing generative AI workload services.
Further Reading
- Five stocks we like better than CrowdStrike
- What is Short Interest? How to Use It
- Intel: Is Now the Time to Be Brave?Â
- Stock Sentiment Analysis: How it Works
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for CrowdStrike Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CrowdStrike and related companies with MarketBeat.com's FREE daily email newsletter.